HomeCompareEKTAF vs DIVO

EKTAF vs DIVO: Dividend Comparison 2026

EKTAF yields 4.14% · DIVO yields 6.49%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 EKTAF wins by $58.3K in total portfolio value· pulled ahead in Year 3
10 years
EKTAF
EKTAF
● Live price
4.14%
Share price
$6.20
Annual div
$0.26
5Y div CAGR
33.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$89.0K
Annual income
$24,064.33
Full EKTAF calculator →
DIVO
DIVO
● Live price
6.49%
Share price
$44.85
Annual div
$2.91
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.7K
Annual income
$981.68
Full DIVO calculator →

Portfolio growth — EKTAF vs DIVO

📍 EKTAF pulled ahead of the other in Year 3

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodEKTAFDIVO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, EKTAF + DIVO cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
EKTAF pays
DIVO pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

EKTAF
Annual income on $10K today (after 15% tax)
$352.23/yr
After 10yr DRIP, annual income (after tax)
$20,454.68/yr
DIVO
Annual income on $10K today (after 15% tax)
$552.00/yr
After 10yr DRIP, annual income (after tax)
$834.43/yr
At 15% tax rate, EKTAF beats the other by $19,620.25/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of EKTAF + DIVO for your $10,000?

EKTAF: 50%DIVO: 50%
100% DIVO50/50100% EKTAF
Portfolio after 10yr
$59.9K
Annual income
$12,523.00/yr
Blended yield
20.91%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

EKTAF buys
0
DIVO buys
0
No recent congressional trades found for EKTAF or DIVO in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricEKTAFDIVO
Forward yield4.14%6.49%
Annual dividend / share$0.26$2.91
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR33.2%0%
Portfolio after 10y$89.0K$30.7K
Annual income after 10y$24,064.33$981.68
Total dividends collected$61.5K$8.2K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: EKTAF vs DIVO ($10,000, DRIP)

YearEKTAF PortfolioEKTAF Income/yrDIVO PortfolioDIVO Income/yrGap
1$11,252$551.96$11,349$649.42$97.00DIVO
2$12,813$773.14$12,833$688.83$20.00DIVO
3← crossover$14,806$1,095.96$14,459$727.90+$347.00EKTAF
4$17,418$1,576.51$16,238$766.49+$1.2KEKTAF
5$20,947$2,308.89$18,179$804.47+$2.8KEKTAF
6$25,869$3,456.43$20,293$841.71+$5.6KEKTAF
7$32,994$5,313.97$22,591$878.14+$10.4KEKTAF
8$43,741$8,437.06$25,087$913.65+$18.7KEKTAF
9$60,727$13,923.91$27,791$948.18+$32.9KEKTAF
10$89,042$24,064.33$30,718$981.68+$58.3KEKTAF

EKTAF vs DIVO: Complete Analysis 2026

EKTAFStock

Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity, a MR-Linac technology; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for advanced image-guided radiation therapy; treatment management solutions; automated and integrated quality assurance solutions; and hardware and software motion management technology. It also provides MOSAIQ Plaza for multidisciplinary cancer care; Elekta Axis Cloud, a managed hosting service; Elekta Studio, an image-guided brachytherapy solution; ImagingRing, a mobile CT scanner; Oncentra Brachy, a smart tool that facilitate repetitive tasks; Venezia applicator that enables the radiation oncologist to treat locally advanced cervical cancer; Elekta Flexitron afterloader for enabling the precise execution of all steps in the workflow; and Geneva, an applicator for cervical cancer treatment. In addition, the company offers Leksell Gamma Knife Icon for personalized radiation treatment; Leksell Gamma Knife Perfexion, a tool for neurosurgeons; Leksell Gamma Knife Lightning for accelerated radiosurgery. Further, it provides neurosurgery products comprising Leksell Vantage Stereotactic System for intracranial neurosurgery; and Leksell Stereotactic System or minimally invasive stereotactic neurosurgery. The company was incorporated in 1972 and is headquartered in Stockholm, Sweden.

Full EKTAF Calculator →

DIVOETF

DIVO is an ETF of high-quality large cap companies with a history of dividend and earnings growth, along with a tactical covered call* strategy on individual stocks. DIVO is strategically designed to offer high levels of total return on a risk-adjusted basis.

Full DIVO Calculator →
📬

Get this EKTAF vs DIVO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

EKTAF vs SCHDEKTAF vs JEPIEKTAF vs OEKTAF vs KOEKTAF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.